|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Malaysia
Espicom Business Intelligence Ltd, Sep 2009, Pages: 54
This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Executive Summary
The government is keen to encourage the local production of drugs, particularly in the fields of biotechnology and the manufacture of off-patent drugs. Several incentives have been put in place, including tax exemptions for biotech companies that are awarded Bionexus status.
By the end of 2008, there were a total 92 companies with Bionexus status, of which 36 focused on healthcare. This was a rise of 119% over the 2007 total of 42 companies; the number of healthcare biotech companies rose 89.5% over the same period from just 19 previously.
Malaysia’s biotech initiative has begun to attract a growing number of multinational companies investing in the country, there have been rising new and ongoing investments in manufacturing plants and research projects in recent times.
Local manufacturers almost exclusively produce generics and other off-patent medicaments, both ethical and OTC products, but imported medicines by multinational manufacturers still command the lion’s share of the market, at over 70% in value terms.
Espicom estimates the Malaysian market to stand at US$1,072 million in 2009, and reach US$1.6 billion in 2014, growing at an impressive average rate of around 8.2% per annum. Per capita spending is expected to grow from US$38 to US$52.
Customers who bought this item also bought
Malaysia Pharmaceuticals & Healthcare Report Q1 2008
Malaysia Pharmaceuticals and Healthcare Report Q1 2009
Malaysia Pharmaceuticals and Healthcare Report Q2 2009
Malaysia Pharmaceuticals and Healthcare Report Q4 2009
Malaysia Pharmaceuticals and Healthcare Report Q3 2009
Malaysia Pharmaceuticals and Healthcare Report Q2 2008
Malaysia Pharmaceuticals and Healthcare Report Q3 2008
DKSH Holdings (Malaysia) Berhad
Malaysia Retail Report Q1 2010
Vitamins and Dietary Supplements in Malaysia: A Strategic Reference, 2006
The 2009 Import and Export Market for Bread, Baked Goods, Pastry, Cakes, Biscuits, Communion Wafers, Empty Cachets for Pharmaceutical Use, Sealing Wafers, and Rice Paper in Malaysia
Malaysia - Pharmaceutical Industry Overview
|
|
|
|
